VRC01 provides sterilizing protection to non human primates from mucosal SHIV challenges

被引：0
|
作者：
Pegu, Amarendra [1 ]
Yang, Zhi-yong [1 ]
Chen, Xuejen [1 ]
Todd, John-Paul [1 ]
McKee, Krisha [1 ]
Rao, Srinivas [1 ]
Mascola, John [1 ]
Nabel, Gary [1 ]
机构：
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
155.11
引用
收藏
页数：2
相关论文
共 23 条
  • [11] A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Cross Protection against Inhalational Glanders in Mice and Non-Human Primates
    Baker, Sarah M.
    Davitt, Christopher J. H.
    Motyka, Natalya
    Kikendall, Nicole L.
    Russell-Lodrigue, Kasi
    Roy, Chad J.
    Morici, Lisa A.
    VACCINES, 2017, 5 (04)
  • [12] A Single Dose Respiratory Recombinant Adenovirus-Based Vaccine Provides Long-Term Protection for Non-Human Primates from Lethal Ebola Infection
    Choi, Jin Huk
    Jonsson-Schmunk, Kristina
    Qiu, Xiangguo
    Shedlock, Devon J.
    Strong, Jim
    Xu, Jason X.
    Michie, Kelly L.
    Audet, Jonathan
    Fernando, Lisa
    Myers, Mark J.
    Weiner, David
    Bajrovic, Irnela
    Tran, Lilian Q.
    Wong, Gary
    Bello, Alexander
    Kobinger, Gary P.
    Schafer, Stephen C.
    Croyle, Maria A.
    MOLECULAR PHARMACEUTICS, 2015, 12 (08) : 2712 - 2731
  • [13] Challenges in Mucosal HIV Vaccine Development: Lessons from Non-Human Primate Models
    Tuero, Iskra
    Robert-Guroff, Marjorie
    VIRUSES-BASEL, 2014, 6 (08): : 3129 - 3158
  • [14] High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
    Bomsel, M.
    Drillet, A.
    Roger, M.
    Amacker, M.
    Mouz, N.
    Lopalco, L.
    Devillers, G.
    Zurbriggen, R.
    Fleury, S.
    RETROVIROLOGY, 2009, 6
  • [15] AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates
    Jeyanathan, Mangalakumari
    Shao, Zhongqi
    Yu, Xuefeng
    Harkness, Robin
    Jiang, Rong
    Li, Junqiang
    Xing, Zhou
    Zhu, Tao
    PLOS ONE, 2015, 10 (08):
  • [16] An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates
    Zabaleta, Nerea
    Dai, Wenlong
    Bhatt, Urja
    Herate, Cecile
    Maisonnasse, Pauline
    Chichester, Jessica A.
    Sanmiguel, Julio
    Estelien, Reynette
    Michalson, Kristofer T.
    Diop, Cheikh
    Maciorowski, Dawid
    Dereuddre-Bosquet, Nathalie
    Cavarelli, Mariangela
    Gallouet, Anne-Sophie
    Naninck, Thibaut
    Kahlaoui, Nidhal
    Lemaitre, Julien
    Qi, Wenbin
    Hudspeth, Elissa
    Cucalon, Allison
    Dyer, Cecilia D.
    Pampena, M. Betina
    Knox, James J.
    LaRocque, Regina C.
    Charles, Richelle C.
    Li, Dan
    Kim, Maya
    Sheridan, Abigail
    Storm, Nadia
    Johnson, Rebecca, I
    Feldman, Jared
    Hauser, Blake M.
    Contreras, Vanessa
    Marlin, Romain
    Fang, Raphael Ho Tsong
    Chapon, Catherine
    van der Werf, Sylvie
    Zinn, Eric
    Ryan, Aisling
    Kobayashi, Dione T.
    Chauhan, Ruchi
    McGlynn, Marion
    Ryan, Edward T.
    Schmidt, Aaron G.
    Price, Brian
    Honko, Anna
    Griffiths, Anthony
    Yaghmour, Sam
    Hodge, Robert
    Betts, Michael R.
    CELL HOST & MICROBE, 2021, 29 (09) : 1437 - +
  • [17] A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates (vol 13, e0192312, 2018)
    Callendret, Benoit
    Vellinga, Jort
    Wunderlich, Kerstin
    Rodriguez, Ariane
    Steigerwald, Robin
    Dirmeier, Ulrike
    Cheminay, Cedric
    Volkmann, Ariane
    Brasel, Trevor
    Carrion, Ricardo
    Giavedoni, Luis D.
    Patterson, Jean L.
    Mire, Chad E.
    Geisbert, Thomas W.
    Hooper, Jay W.
    Weijtens, Mo
    Hartkoorn-Pasma, Jutta
    Custers, Jerome
    Pau, Maria Grazia
    Schuitemaker, Hanneke
    Zahn, Roland
    PLOS ONE, 2018, 13 (04):
  • [18] P19-02. High protection of female macaques from repeated intravaginal challenges with SHIV-162P3 upon mucosal vaccination with Gp41 subunits-virosomes
    M Bomsel
    A Drillet
    M Roger
    M Amacker
    N Mouz
    L Lopalco
    G Devillers
    R Zurbriggen
    S Fleury
    Retrovirology, 6
  • [19] Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates
    White, Andrew D.
    Tran, Andy C.
    Sibley, Laura
    Sarfas, Charlotte
    Morrison, Alexandra L.
    Lawrence, Steve
    Dennis, Mike
    Clark, Simon
    Zadi, Sirine
    Lanni, Faye
    Rayner, Emma
    Copland, Alastair
    Hart, Peter
    Diogo, Gil Reynolds
    Paul, Matthew J.
    Kim, Miyoung
    Gleeson, Fergus
    Salguero, Francisco J.
    Singh, Mahavir
    Stehr, Matthias
    Cutting, Simon M.
    Basile, Juan I.
    Rottenberg, Martin E.
    Williams, Ann
    Sharpe, Sally A.
    Reljic, Rajko
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [20] Broadly neutralizing humanized SARS-CoV-2 antibody binds to a conserved epitope on Spike and provides antiviral protection through inhalation-based delivery in non-human primates
    Hermet, Paule
    Delache, Benoit
    Herate, Cecile
    Wolf, Esther
    Kivi, Gaily
    Juronen, Erkki
    Mumm, Karl
    Zusinaite, Eva
    Kainov, Denis
    Sankovski, Eve
    Virumae, Kai
    Planken, Anu
    Merits, Andres E.
    Besaw, Jessica E.
    Yee, Ai Woon
    Morizumi, Takefumi
    Kim, Kyumhyuk
    Kuo, Anling
    Berriche, Asma
    Dereuddre-Bosquet, Nathalie
    Sconosciuti, Quentin
    Naninck, Thibaut
    Relouzat, Francis
    Cavarelli, Mariangela
    Ustav, Mart
    Wilson, Derek P.
    Ernst, Oliver P.
    Mannik, Andres
    LeGrand, Roger
    PLOS PATHOGENS, 2023, 19 (08)
123